Table 2.
COMPASS-31 scores and subdomain scores in scleroderma compared to previously published healthy controls (n=30) (20) and patients with other diseases that present with autonomic symptoms, including fibromyalgia (n=30) (20), diabetic polyneuropathy (n=29) (19), and small-fiber polyneuropathy (n=66) (17). Data are presented as mean (standard deviation).
Subdomain | Scleroderma | Healthy Controls | Fibromyalgia | Diabetic polyneuropathy | Small-fiber polyneuropathy |
---|---|---|---|---|---|
Orthostatic | 8.2 (9.3) | 2.9 (6.4) | 9.2 (8.5) | 11.2 (12.4) | 14.0 (12.4) |
Vasomotor | 2.6 (1.4) | 0.1 (0.3) | 0.8 (1.3) | 1.0 (1.4) | 1.6 (2.1) |
Secretomotor | 4.8 (3.3) | 1.1 (2.4) | 4.9 (3.2) | 5.5 (3.6) | 5.4 (6.9) |
Gastrointestinal | 7.7 (4.9) | 3.1 (2.7) | 8.4 (4.4) | 8.1 (4.8) | 6.6 (5.4) |
Urinary | 0.9 (1.3) | 0.5 (0.9) | 1.8 (1.6) | 1.6 (2.0) | 1.0 (1.6) |
Pupillomotor | 1.6 (1.1) | 1.2 (0.8) | 2.4 (1.1) | 2.2 (1.3) | 1.7 (1.4) |
Total COMPASS-31 | 24.9 (15.5) | 8.9 (8.7) | 27.5 (14.2) | 28.9 (19.1) | 30.2 (23.2) |